Literature DB >> 22181323

Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia.

Anhar Hassan1, Joseph E Parisi, Keith A Josephs.   

Abstract

BACKGROUND: Progressive supranuclear palsy (PSP) is a neurodegenerative disorder pathologically characterized by neuronal loss, gliosis and tau-positive neurofibrillary tangles in basal ganglia, brainstem and cerebellar nuclei. Five presenting clinical syndromes of PSP are well-described: (i) the classic Richardson's syndrome; (ii) asymmetric parkinsonism with tremor; (iii) freezing of gait; (iv) asymmetric limb apraxia, and (v) apraxia of speech. AIM: To determine whether autopsy-proven PSP cases may present with another clinical phenotype.
METHODS: Medical records of 66 autopsy-proven PSP cases between 1973 and 2010 were reviewed to determine whether all could be classified into one of five well-defined syndromes listed above. Three cases presented with prominent behavioral and personality changes, meeting diagnosis of behavioral variant frontotemporal dementia. MRI midbrain and pons volumes and pons/midbrain ratios were compared to healthy controls and typical PSP cases.
RESULTS: All three bvFTD cases developed at least one PSP symptom or sign that emerged up to 5 years after initial presentation. One case was re-diagnosed as PSP 6 years after presentation as bvFTD. Compared to controls, midbrain volume was significantly smaller in both bvFTD (p = .03) and PSP cases (p = .008), without significant difference between PSP and bvFTD cases (.44). However pontine volumes were similar across all three groups.
CONCLUSIONS: While most autopsy-confirmed PSP cases present with one of the five well-described syndromes, there are cases that may present as bvFTD. In these, at least one cardinal symptom or sign of PSP later emerges, associated with smaller midbrain volume and increased pons/midbrain ratio. Thus underlying PSP pathology should be considered in these cases.

Entities:  

Mesh:

Year:  2011        PMID: 22181323     DOI: 10.1080/13554794.2011.627345

Source DB:  PubMed          Journal:  Neurocase        ISSN: 1355-4794            Impact factor:   0.881


  30 in total

Review 1.  Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.

Authors:  Adam L Boxer; Jin-Tai Yu; Lawrence I Golbe; Irene Litvan; Anthony E Lang; Günter U Höglinger
Journal:  Lancet Neurol       Date:  2017-06-13       Impact factor: 44.182

Review 2.  Recognizing Atypical Parkinsonisms: "Red Flags" and Therapeutic Approaches.

Authors:  Nikolaus R McFarland; Christopher W Hess
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

Review 3.  Diagnostic Approach to Atypical Parkinsonian Syndromes.

Authors:  Nikolaus R McFarland
Journal:  Continuum (Minneap Minn)       Date:  2016-08

4.  Progressive Supranuclear Palsy and Corticobasal Degeneration.

Authors:  David G Coughlin; Dennis W Dickson; Keith A Josephs; Irene Litvan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Behavioral abnormalities in progressive supranuclear palsy.

Authors:  Adam Gerstenecker; Kevin Duff; Benjamin Mast; Irene Litvan
Journal:  Psychiatry Res       Date:  2013-09-12       Impact factor: 3.222

6.  Dysphagia in Progressive Supranuclear Palsy.

Authors:  Heather M Clark; Julie A G Stierwalt; Nirubol Tosakulwong; Hugo Botha; Farwa Ali; Jennifer L Whitwell; Keith A Josephs
Journal:  Dysphagia       Date:  2019-11-01       Impact factor: 3.438

Review 7.  Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants.

Authors:  G Lopez; K Bayulkem; M Hallett
Journal:  Acta Neurol Scand       Date:  2016-01-06       Impact factor: 3.209

8.  An Evaluation of the Progressive Supranuclear Palsy Speech/Language Variant.

Authors:  Jennifer L Whitwell; Chase A Stevens; Joseph R Duffy; Heather M Clark; Mary M Machulda; Edythe A Strand; Peter R Martin; Rene L Utianski; Hugo Botha; Anthony J Spychalla; Matthew L Senjem; Christopher G Schwarz; Clifford R Jack; Farwa Ali; Anhar Hassan; Keith A Josephs
Journal:  Mov Disord Clin Pract       Date:  2019-05-29

9.  Utility of the Movement Disorders Society Criteria for Progressive Supranuclear Palsy in Clinical Practice.

Authors:  Farwa Ali; Hugo Botha; Jennifer L Whitwell; Keith A Josephs
Journal:  Mov Disord Clin Pract       Date:  2019-07-24

10.  Tau Imaging in Parkinsonism: What Have We Learned So Far?

Authors:  Jennifer L Whitwell
Journal:  Mov Disord Clin Pract       Date:  2017-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.